Efficacy of Intra-articular Growth Factor Concentrate in the Management of Knee Osteoarthritis: A Retrospective Analysis from a Tertiary Care Center in the Hilly Regions of Uttarakhand
Indian Journal of Pain · 2026-01 · 40 (1) · 25-29
DOI: 10.4103/ijpn.ijpn_103_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pain, online erschienen am 31.03.2026. Verfasst von Manasa Kantha und 6 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Knee osteoarthritis (KOA) is a degenerative joint disorder leading to pain and functional impairment. Intra-articular growth factor concentrate (GFC), a refined derivative of platelet-rich plasma, is emerging as a regenerative treatment modality with potential chondroprotective and analgesic effects.
Objectives
The objective of this study was to evaluate the efficacy and safety of intra-articular GFC in reducing pain, improving function, and promoting cartilage thickness in patients with moderate KOA living in hilly regions of Uttarakhand. Methodology: A retrospective observational study was conducted at a tertiary care center in Uttarakhand. Fifty patients aged 40–75 years with Kellgren–Lawrence Grade II–III KOA and Numerical Rating Scale (NRS) ≥4 were included. Patients received GFC injections and were assessed at baseline, 3 weeks, 6 weeks, and 3 months. Primary outcome was pain relief (NRS); secondary outcomes included cartilage thickness (ultrasound), WOMAC score, and adverse events. Statistical analysis was performed using repeated measures analysis of variance.
Results
The mean NRS scores significantly decreased from 7.2 to 2.5 at 3 months ( P = 0.007). Cartilage thickness improved from 2.57 mm to 2.88 mm ( P = 0.002). WOMAC score showed significant improvement (23.06% reduction; P < 0.01). Only one patient (1.96%) reported mild local soreness, indicating a favorable safety profile.
Conclusions
Intra-articular GFC demonstrated significant pain relief, functional improvement, and increased cartilage thickness over 3 months in moderate KOA patients living in hilly regions of Uttarakhand with minimal adverse effects. These findings support GFC as a viable regenerative therapy in conservative osteoarthritis management. Prospective, long-term studies are warranted.
Zitieren
APA
Kantha, M., Kumar, A., Saini, S., Arya, M., Bangari, S., Sharma, K., & Chisti, S. A. (2026). Efficacy of Intra-articular Growth Factor Concentrate in the Management of Knee Osteoarthritis: A Retrospective Analysis from a Tertiary Care Center in the Hilly Regions of Uttarakhand. Indian Journal of Pain, 40(1), 25-29. https://doi.org/10.4103/ijpn.ijpn_103_25
Vancouver
Kantha M, Kumar A, Saini S, Arya M, Bangari S, Sharma K, et al. Efficacy of Intra-articular Growth Factor Concentrate in the Management of Knee Osteoarthritis: A Retrospective Analysis from a Tertiary Care Center in the Hilly Regions of Uttarakhand. Indian Journal of Pain. 2026;40(1):25-29. doi:10.4103/ijpn.ijpn_103_25
BibTeX
@article{Kantha2026,
author = {Kantha, Manasa and Kumar, Ajit and Saini, Shruthi and Arya, Mynu and Bangari, Samriddhi and Sharma, Komal and Chisti, Saif Ali},
title = {Efficacy of Intra-articular Growth Factor Concentrate in the Management of Knee Osteoarthritis: A Retrospective Analysis from a Tertiary Care Center in the Hilly Regions of Uttarakhand},
journal = {Indian Journal of Pain},
year = {2026},
volume = {40},
number = {1},
pages = {25--29},
doi = {10.4103/ijpn.ijpn_103_25}
}
EUVIMED